GHENT, Belgio–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, azienda di HealthTech (tecnologia sanitaria) che progetta il futuro della vista, oggi ha annunciato la prima conclusione del suo round di finanziamento di Serie A da 15 milioni di euro, racc…
Author: Business Wire
Azalea Vision完成A轮融资首次交割，募集900万欧元以进一步开发智能互联视觉平台
比利时根特–(BUSINESS WIRE)–(美国商业资讯)– 致力于开创视力未来的医疗科技公司Azalea (A-zuh-lay-ah) Vision今日宣布，其1500万欧元A轮融资已完成首次交割，成功募集900万欧元。同时，公司任命Robert J. Dempsey为董事会主席，以指导公司在欧洲和美国市场的战略发展。 Azalea Vision首席执行官Enrique Vega表示：“在这一A轮融资里程碑中，老投资者的踊跃参与再次证明了他们对我们的医疗器械以及为推动智能眼部健康未来所开展…
Azalea Vision lève 9 millions EUR dans le cadre de la clôture de la première phase d’un financement de série A pour poursuivre le développement de sa plateforme intelligente de vision connectée
GAND, Belgique–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, une société de heathtech qui conçoit l’avenir de la vue, vient d’annoncer aujourd’hui la clôture de la première phase de son cycle de financement de série A de 15 millions EUR, dans le cadr…
Azalea Vision完成A輪融資首次交割，籌集900萬歐元以進一步開發智慧互聯視覺平台
比利時根特–(BUSINESS WIRE)–(美國商業資訊)– 致力於開創視力未來的醫療科技公司Azalea (A-zuh-lay-ah) Vision今日宣布，其1500萬歐元A輪融資已完成首次交割，成功籌集900萬歐元。同時，公司任命Robert J. Dempsey為董事長，以指導公司在歐洲和美國市場的策略發展。 Azalea Vision執行長Enrique Vega表示：「在這一A輪融資里程碑中，重複投資人的踴躍參與再次證明了他們對我們的醫療器材以及為推動智慧眼部健康未來所展開創新的…
Samenvatting: Azalea Vision haalt €9 miljoen op in de eerste afsluiting van een Serie A-financieringsronde om het Intelligent Connected Vision Platform verder te ontwikkelen
GENT, België–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, een HealthTech-bedrijf dat de toekomst van het zichtvermogen vorm geeft, kondigde vandaag de eerste afsluiting van haar Serie A-financieringsronde van €15 miljoen aan, waarbij €9 miljoen werd…
Azalea Vision recauda 9 millones de euros en el primer cierre de su ronda de Serie A para impulsar su plataforma de visión conectada inteligente
GHENT, Bélgica–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, empresa de tecnología sanitaria (HealthTech) que diseña el futuro de la visión, acaba de anunciar el primer cierre de su ronda de financiación de Serie A de 15 millones de euros, con la que…
Azalea Vision arrecada 9 milhões de euros na primeira fase de financiamento de Série A para continuar desenvolvendo sua plataforma de visão inteligente conectada
GHENT, Bélgica–(BUSINESS WIRE)–A Azalea (A-zuh-lay-ah) Vision, uma empresa de tecnologia da saúde que está projetando o futuro da visão, anunciou hoje o primeiro fechamento de sua rodada de financiamento de Série A no valor de 15 milhões de euros, ar…
Azalea Vision sammelt 9 Millionen Euro in erster Finanzierungsrunde der Serie A zur Weiterentwicklung seiner intelligenten vernetzten Bildverarbeitungsplattform
GHENT, Belgien–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, ein HealthTech-Unternehmen, das die Zukunft des Sehens gestaltet, gab heute den ersten Abschluss seiner Serie-A-Finanzierungsrunde in Höhe von 15 Millionen Euro bekannt. Dabei wurden 9 Mill…
Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the…
National Vision Appoints Alex Wilkes as CEO
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that its Board of Directors has appointed Alex Wilkes as the Company’s next Chief Executive Officer, effective August 1, 202…
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform
GHENT, Belgium–(BUSINESS WIRE)– #ALMA–Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appointment of R…
Heidelberg Engineering Showcases the Future of Imaging Technology at ARVO 2025, Leading the Way From the Lab to the Operating Room
HEIDELBERG, Germany–(BUSINESS WIRE)–Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, welcomes delegates at ARVO 2025 to experience the latest research and technological developments behind Heidelberg image …
Astoriom Appoints Ryan Smith as Global Head of Sales
ROCHDALE, England–(BUSINESS WIRE)– #Astoriom–Astoriom appoints Ryan Smith as Global Head of Sales to support company in scaling biorepository and stability storage operations.
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
CHICAGO–(BUSINESS WIRE)–EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority g…
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
GENEVA–(BUSINESS WIRE)–Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
STAAR Surgical Announces Changes to Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The C…
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8…
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its recent voluntary recal…
GenSight Biologics Annual General Meeting on May 13, 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…